IT8422739A1 - Nuovi derivati nucleosidici e purinici 8-sostituiti - Google Patents

Nuovi derivati nucleosidici e purinici 8-sostituiti

Info

Publication number
IT8422739A1
IT8422739A1 IT1984A22739A IT2273984A IT8422739A1 IT 8422739 A1 IT8422739 A1 IT 8422739A1 IT 1984A22739 A IT1984A22739 A IT 1984A22739A IT 2273984 A IT2273984 A IT 2273984A IT 8422739 A1 IT8422739 A1 IT 8422739A1
Authority
IT
Italy
Prior art keywords
sub
new
purine derivatives
substituted nucleoside
hydrogen
Prior art date
Application number
IT1984A22739A
Other languages
English (en)
Other versions
IT1196261B (it
IT8422739A0 (it
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of IT8422739A0 publication Critical patent/IT8422739A0/it
Priority to IT22739/84A priority Critical patent/IT1196261B/it
Priority to PT81045A priority patent/PT81045B/pt
Priority to DE8585111690T priority patent/DE3568783D1/de
Priority to US06/776,472 priority patent/US4774325A/en
Priority to ZA857075A priority patent/ZA857075B/xx
Priority to AT85111690T priority patent/ATE41430T1/de
Priority to EP85111690A priority patent/EP0175325B1/en
Priority to GR852261A priority patent/GR852261B/el
Priority to CA000491088A priority patent/CA1268175A/en
Priority to DK426185A priority patent/DK167318B1/da
Priority to AU47672/85A priority patent/AU591462B2/en
Priority to NZ213550A priority patent/NZ213550A/xx
Priority to JP60208571A priority patent/JPS61112077A/ja
Priority to ES547856A priority patent/ES8701773A1/es
Priority to CN 85108905 priority patent/CN1024278C/zh
Publication of IT8422739A1 publication Critical patent/IT8422739A1/it
Application granted granted Critical
Publication of IT1196261B publication Critical patent/IT1196261B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT22739/84A 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti IT1196261B (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT22739/84A IT1196261B (it) 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti
PT81045A PT81045B (pt) 1984-09-20 1985-08-28 Processo para a preparacao de novos derivados do nucleosido e da purina 8-substituidos, e de composicoes farmaceuticas contendo-os
DE8585111690T DE3568783D1 (en) 1984-09-20 1985-09-16 New 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
US06/776,472 US4774325A (en) 1984-09-20 1985-09-16 New 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
ZA857075A ZA857075B (en) 1984-09-20 1985-09-16 New 8-substituted nucleoside and purine derivatives,the process for the preparation thereof and the pharmaceutical compositions containing them
AT85111690T ATE41430T1 (de) 1984-09-20 1985-09-16 8-substituierte nukleosid- und purinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
EP85111690A EP0175325B1 (en) 1984-09-20 1985-09-16 New 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
GR852261A GR852261B (it) 1984-09-20 1985-09-17
CA000491088A CA1268175A (en) 1984-09-20 1985-09-19 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
DK426185A DK167318B1 (da) 1984-09-20 1985-09-19 8-substituerede puriner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende forbindelserne
AU47672/85A AU591462B2 (en) 1984-09-20 1985-09-19 New 8-substituted nucleoside and purine derivaties, the process for the preparation thereof and the pharmaceutical compositions containing them
NZ213550A NZ213550A (en) 1984-09-20 1985-09-19 Purine-substituted nucleoside derivatives and pharmaceutical compositions
JP60208571A JPS61112077A (ja) 1984-09-20 1985-09-20 ８−置換されたヌクレオシド及びプリン誘導体
ES547856A ES8701773A1 (es) 1984-09-20 1985-09-20 Procedimiento de preparar derivados de nucleosidos y purinas8-substituidos
CN 85108905 CN1024278C (zh) 1984-09-20 1985-12-11 8-位上取代的核苷及嘌呤衍生物的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22739/84A IT1196261B (it) 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti

Publications (3)

Publication Number Publication Date
IT8422739A0 IT8422739A0 (it) 1984-09-20
IT8422739A1 true IT8422739A1 (it) 1986-03-20
IT1196261B IT1196261B (it) 1988-11-16

Family

ID=11199882

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22739/84A IT1196261B (it) 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti

Country Status (14)

Country Link
US (1) US4774325A (it)
EP (1) EP0175325B1 (it)
JP (1) JPS61112077A (it)
AT (1) ATE41430T1 (it)
AU (1) AU591462B2 (it)
CA (1) CA1268175A (it)
DE (1) DE3568783D1 (it)
DK (1) DK167318B1 (it)
ES (1) ES8701773A1 (it)
GR (1) GR852261B (it)
IT (1) IT1196261B (it)
NZ (1) NZ213550A (it)
PT (1) PT81045B (it)
ZA (1) ZA857075B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
IT1248528B (it) * 1991-06-21 1995-01-19 Pierrel Spa Derivati di eteri e tioeteri (etero) aromatici aventi attivita` antiiperlipidemica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
US5233041A (en) * 1991-10-07 1993-08-03 Glaxo Group Limited Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a 2,3-unsaturated-1-cyclopentanylpurinone
EP0691968B1 (en) * 1993-03-30 1997-07-16 Sanofi Acyclic nucleoside analogs and oligonucleotide sequences containing them
US5329008A (en) * 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
US5969135A (en) * 1995-11-02 1999-10-19 Icn Pharmaceuticals, Inc. Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
CA2440809A1 (en) * 2001-03-01 2002-09-12 Conforma Therapeutics Corp. Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
EP1440072A4 (en) * 2001-10-30 2005-02-02 Conforma Therapeutic Corp PURINE ANALOGS HAVING HSP90 INHIBITORY ACTIVITY
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
JP3929949B2 (ja) * 2003-08-08 2007-06-13 独立行政法人科学技術振興機構 酸化により機能性ユニットを放出するヌクレオシドおよびそれを含むオリゴヌクレオチドの製造法
NZ546611A (en) 2003-09-18 2010-02-26 Conforma Therapeutics Corp Novel heterocyclic compounds as HSP90-inhibitors
BRPI0609509A2 (pt) * 2005-03-30 2010-04-13 Conforma Therapeutics Corp composto ou um polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso do composto, polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável
US20070105874A1 (en) * 2005-09-23 2007-05-10 Conforma Therapeutics Corporation Anti-Tumor Methods Using Multi Drug Resistance Independent Synthetic HSP90 Inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE111312C (it) * 1897-12-16
US2819260A (en) * 1953-06-04 1958-01-07 Petrolite Corp Process for preparing oxyalkylated derivatives
US3391196A (en) * 1965-08-16 1968-07-02 Wyandotte Chemicals Corp High equivalent weight hydroxy-terminated ethylene oxide-butylene oxide polyether polyols
US3712885A (en) * 1968-09-10 1973-01-23 G Weimann Purine-ribofuranoside-3',5'-cyclophosphates and process for their preparation
JPS5133799B2 (it) * 1973-06-14 1976-09-21
US4048307A (en) * 1974-12-26 1977-09-13 Asahi Kasei Kogyo Kabushiki Kaisha Cyclic adenosine monophosphate 8-substituted derivatives
DE2631046A1 (de) * 1975-07-15 1977-01-20 Snam Progetti Adeninderivate und verfahren zu deren herstellung
SU883056A1 (ru) * 1980-03-26 1981-11-23 Ленинградский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.А.А.Жданова Способ получени [8-(6-аминогексил)-амино]-аденозин-5-дифосфата
DE3027279A1 (de) * 1980-07-18 1982-05-06 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3169373D1 (en) * 1980-08-06 1985-04-25 Shell Int Research Process for the manufacture of polyether polyols and their use for preparing polyurethanes
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体

Also Published As

Publication number Publication date
ES547856A0 (es) 1987-01-01
JPH0569109B2 (it) 1993-09-30
DK426185A (da) 1986-03-21
AU591462B2 (en) 1989-12-07
EP0175325B1 (en) 1989-03-15
DK167318B1 (da) 1993-10-11
PT81045B (pt) 1987-09-18
ES8701773A1 (es) 1987-01-01
DK426185D0 (da) 1985-09-19
US4774325A (en) 1988-09-27
ATE41430T1 (de) 1989-04-15
DE3568783D1 (en) 1989-04-20
EP0175325A3 (en) 1987-02-04
IT1196261B (it) 1988-11-16
IT8422739A0 (it) 1984-09-20
JPS61112077A (ja) 1986-05-30
PT81045A (en) 1985-09-01
GR852261B (it) 1986-01-17
CA1268175A (en) 1990-04-24
EP0175325A2 (en) 1986-03-26
ZA857075B (en) 1986-06-25
AU4767285A (en) 1986-03-27
NZ213550A (en) 1989-06-28

Similar Documents

Publication Publication Date Title
IT1196261B (it) Derivati nucleosidici e purinici 8-sostituiti
AU576555B2 (en) 1-fluorophenylbutyl-4-(2-pyrimidinyl) piperazine derivatives
ES8800888A1 (es) Procedimiento para la preparacion de compuestos analogos in-denicos de la mevalonolactona y sus derivados
ES8306767A1 (es) "metodo de preparar compuestos esteroidicos antiinflamatorios".
IT8521865A0 (it) Derivati di etilendiamminomonoammidi.
ES505106A0 (es) Procedimiento para la produccion de derivados de piperidile-no
DE3671896D1 (de) Herstellung von cytosin-nukleosiden.
PT702683E (pt) Derivados de guanina o6-substituida processo para a sua preparacao e sua utilizacao no tratamento de celulas tumorais
DE3581633D1 (de) Gegen unkrautvertilgende glutaminsynthetase-inhibitoren resistente pflanzenzellen.
EP0254902A3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
IT1203608B (it) Derivati di prolina
ATE31295T1 (de) Benzoylharnstoffderivate.
DK333785D0 (da) Mevalonolactonderivater
ES2052526T3 (es) Derivados de pirimidina, su preparacion y medicamentos que contienen estos derivados.
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
ATE54307T1 (de) Pantothenolderivate.
ES2030246T3 (es) Procedimiento para la obtencion de derivados de benzofurano y fungicidas que contienen estos compuestos.
IT1187699B (it) 1-(2-pirimidinil)-piperazinil derivati di 1-pirrolidin-2-onipsicogeriatrici
MY116824A (en) Antivaral,highly water soluble,stable,crystalline salts of 2'',3''-dideoxyinosine monohydrate,2'',3''-dideoxy-2'' ,3''-didehydrothymidine monohydrate and 2'',3''-dideoxy-2''-fluoroinosine hemihydrate
ES474350A1 (es) Procedimiento para la obtencion de derivados de la tiazolina.
IE893533L (en) Substituted 3-aminosydnonimines, processes for their¹preparation and their use
ATE65986T1 (de) Propanolabkoemmlinge.
SU1266156A1 (ru) 7-морфолинокумарины в качестве красителей для лазерной техники
BG49444A1 (en) Acylureidoamynotiasolylni derivatives and method for their preparation
ATE61352T1 (de) 4-hydroxy-4-(substituierte alkenyl)cyclohexancarbons|ure.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950928